Yi Shen

2.6k total citations · 1 hit paper
49 papers, 2.0k citations indexed

About

Yi Shen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yi Shen has authored 49 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 15 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Yi Shen's work include Cancer-related molecular mechanisms research (9 papers), Circular RNAs in diseases (6 papers) and RNA Research and Splicing (6 papers). Yi Shen is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), Circular RNAs in diseases (6 papers) and RNA Research and Splicing (6 papers). Yi Shen collaborates with scholars based in United States, China and Italy. Yi Shen's co-authors include Wen Jin Wu, Herbert Yu, Dianne S. Hirsch, Dionyssios Katsaros, Cornelia M. Weyand, Jörg J. Goronzy, Zhanwei Wang, Harvey A. Risch, Dan Peng and Yuanyuan Fu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Immunology and The Journal of Immunology.

In The Last Decade

Yi Shen

45 papers receiving 2.0k citations

Hit Papers

A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apopt... 2018 2026 2020 2023 2018 100 200 300 400

Peers

Yi Shen
Yi Bao China
Yao Zhang China
Ye Zhang China
Xian Lin China
Jian-Jun Wei United States
Linda Xu United States
Yi Bao China
Yi Shen
Citations per year, relative to Yi Shen Yi Shen (= 1×) peers Yi Bao

Countries citing papers authored by Yi Shen

Since Specialization
Citations

This map shows the geographic impact of Yi Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Shen more than expected).

Fields of papers citing papers by Yi Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Shen. The network helps show where Yi Shen may publish in the future.

Co-authorship network of co-authors of Yi Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Shen. A scholar is included among the top collaborators of Yi Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Shen. Yi Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Yi, et al.. (2024). Modifiable risk factors for thyroid cancer: lifestyle and residence environment. Endokrynologia Polska. 75(2). 119–129. 7 indexed citations
2.
Shen, Yi, et al.. (2024). Monotropein mitigates methotrexate-induced liver injury by activating autophagy and inhibiting ferroptosis. Journal of Functional Foods. 121. 106413–106413. 1 indexed citations
4.
Peng, Qiliang, et al.. (2024). LC–MS metabolomics analysis of serum metabolites during neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Clinical & Translational Oncology. 26(12). 3150–3168. 1 indexed citations
5.
Gu, Lei, Wencheng Zhu, Yi Shen, et al.. (2023). Ultrasensitive proteomics depicted an in-depth landscape for the very early stage of mouse maternal-to-zygotic transition. Journal of Pharmaceutical Analysis. 13(8). 942–954. 8 indexed citations
6.
Hong, Zheping, et al.. (2021). The effects of MEX3A knockdown on proliferation, apoptosis and migration of osteosarcoma cells. Cancer Cell International. 21(1). 197–197. 10 indexed citations
7.
Shen, Yi, Harvey A. Risch, Lingeng Lu, et al.. (2020). Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case–control study. Cancer Causes & Control. 31(4). 321–332. 20 indexed citations
8.
Li, Yinyin, Yi Shen, Ke Jin, et al.. (2019). The DNA Repair Nuclease MRE11A Functions as a Mitochondrial Protector and Prevents T Cell Pyroptosis and Tissue Inflammation. Cell Metabolism. 30(3). 477–492.e6. 142 indexed citations
9.
Wang, Zhanwei, Dionyssios Katsaros, Nicoletta Biglia, et al.. (2019). ERα upregulates the expression of long non-coding RNA LINC00472 which suppresses the phosphorylation of NF-κB in breast cancer. Breast Cancer Research and Treatment. 175(2). 353–368. 41 indexed citations
10.
Mao, Chao, Xiang Wang, Yating Liu, et al.. (2018). A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53. Cancer Research. 78(13). 3484–3496. 402 indexed citations breakdown →
11.
Zhu, Wei, Ziqing Yin, Qiang Zhang, et al.. (2018). Proanthocyanidins inhibit osteoclast formation and function by inhibiting the NF-κB and JNK signaling pathways during osteoporosis treatment. Biochemical and Biophysical Research Communications. 509(1). 294–300. 38 indexed citations
12.
Wang, Zhanwei, Dionyssios Katsaros, Nicoletta Biglia, et al.. (2018). High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival. Breast Cancer Research and Treatment. 171(2). 261–271. 57 indexed citations
13.
Fu, Yuanyuan, Nicoletta Biglia, Zhanwei Wang, et al.. (2016). Long non-coding RNAs, ASAP1-IT1, FAM215A, and LINC00472, in epithelial ovarian cancer. Gynecologic Oncology. 143(3). 642–649. 52 indexed citations
14.
Shen, Yi, Zhanwei Wang, Lenora W. M. Loo, et al.. (2015). LINC00472 expression is regulated by promoter methylation and associated with disease-free survival in patients with grade 2 breast cancer. Breast Cancer Research and Treatment. 154(3). 473–482. 54 indexed citations
15.
He, Yi, Qing Zhang, Yi Shen, et al.. (2014). Schisantherin A suppresses osteoclast formation and wear particle-induced osteolysis via modulating RANKL signaling pathways. Biochemical and Biophysical Research Communications. 449(3). 344–350. 39 indexed citations
16.
Qin, Lifeng, Wanchun Wang, Han Fang, et al.. (2013). Expression of NF-κB and osteopontin of synovial fluid of patients with knee osteoarthritis. Asian Pacific Journal of Tropical Medicine. 6(5). 379–382. 13 indexed citations
17.
Zificsak, Craig A., Yi Shen, Joseph G. Lisko, et al.. (2012). Synthesis and biological evaluation of sulfonyl acrylonitriles as novel inhibitors to peritoneal carcinomatosis. Bioorganic & Medicinal Chemistry Letters. 22(5). 1850–1853. 11 indexed citations
18.
Shen, Yi, et al.. (2011). Pharmacologic downregulation of c‐FLIPL restores juxtacrine death receptor‐mediated apoptosis in cancer cells in a peritoneal carcinomatosis model. International Journal of Cancer. 130(7). 1494–1503. 6 indexed citations
19.
Gao, Rui, Jing Wang, Yi Shen, Ming Lei, & Zehua Wang. (2009). Functional expression of voltage-gated sodium channels Nav1.5 in human breast caner cell line MDA-MB-231. Journal of Huazhong University of Science and Technology [Medical Sciences]. 29(1). 64–67. 18 indexed citations
20.
Wu, Zheng-Qi, Yi Shen, Abdul Qayyum Khan, et al.. (2002). The Mechanism Underlying T Cell Help for Induction of an Antigen-Specific In Vivo Humoral Immune Response to Intact Streptococcus pneumoniae Is Dependent on the Type of Antigen. The Journal of Immunology. 168(11). 5551–5557. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026